ChemoCentryx Shares 2011-2025 | CCXI

Annual Shares ChemoCentryx

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
69.9 K	65.7 M	56.9 M	49.8 M	48.4 M	46.4 M	43.9 M	43.3 M	40.9 M	35.4 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
65.7 M	69.9 K	43.1 M

Quarterly Shares ChemoCentryx

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	71.2 K	70.8 K	70.4 M	69.9 M	69.8 K	69.6 K	69.5 M	68.9 M	63.3 M	61.3 M	60.2 M	58.2 M	58.1 M	52.4 K	50.7 M	50.3 K	49.5 K	48.9 K	48.8 M	48.6 M	48.2 M	48.1 M	48.1 M	47.8 K	45.8 K	44.3 K	44.2 M	44.1 K	43.8 K	43.5 K	43.4 M	43.3 M	43.3 M	43.1 M	42.9 M	42.8 M	41.3 M	36.6 M	36.4 M	36.2 M	36.2 M	32.9 M	4.39 M	4.2 M	4.15 M	4.39 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
70.4 M	43.5 K	30.7 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	294 M	$ 3.56	-2.51 %	$ 1.05 B	Canada
AC Immune SA ACIU	75 M	$ 2.82	-2.07 %	$ 229 M	Schweiz
ADiTx Therapeutics ADTX	13.2 K	$ 3.05	4.81 %	$ 40.2 K	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
Abeona Therapeutics ABEO	21.4 M	$ 4.81	-1.23 %	$ 103 M	USA
ARCA biopharma ABIO	16.8 M	-	1052.0 %	$ 415 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Amneal Pharmaceuticals AMRX	309 M	$ 11.96	0.13 %	$ 3.7 B	USA
Axcella Health AXLA	54.4 M	-	-16.42 %	$ 249 M	USA
Acer Therapeutics ACER	15.8 M	-	2.71 %	$ 14 M	USA
Atreca BCEL	38.6 M	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	5.02 M	-	-2.5 %	$ 5.88 M	USA
argenx SE ARGX	51.1 M	$ 901.39	-1.59 %	$ 25 B	Niderland
Armata Pharmaceuticals ARMP	36.1 M	$ 5.88	1.03 %	$ 212 M	USA
Achieve Life Sciences ACHV	19.8 M	$ 4.69	-1.88 %	$ 93 M	USA
BioDelivery Sciences International BDSI	99.3 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	1.37 B	-	0.49 %	$ 251 B	Cayman-islands
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Ascendis Pharma A/S ASND	54.8 M	$ 206.12	-1.18 %	$ 5 B	Danmark
Alterity Therapeutics Limited ATHE	2.41 B	$ 3.36	-1.95 %	$ 8.08 B	Australia
Autolus Therapeutics plc AUTL	255 M	$ 1.54	-1.92 %	$ 393 M	Britain
Acasti Pharma ACST	12.1 M	-	4.01 %	$ 150 M	Canada
Bellerophon Therapeutics BLPH	9.55 M	-	-74.18 %	$ 955 K	USA
Adaptimmune Therapeutics plc ADAP	1.21 B	-	-15.15 %	$ 60.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Baudax Bio BXRX	332 K	-	0.59 %	$ 63 K	USA
AbbVie ABBV	1.77 B	$ 226.39	-1.0 %	$ 400 B	USA
Cara Therapeutics CARA	54.1 M	-	-3.03 %	$ 260 M	USA
CymaBay Therapeutics CBAY	106 M	-	-	$ 3.45 B	USA
Codiak BioSciences CDAK	21.8 M	-	-55.98 %	$ 2.15 M	USA
Adaptive Biotechnologies Corporation ADPT	147 M	$ 15.13	-13.34 %	$ 2.23 B	USA
BioLineRx Ltd. BLRX	663 M	$ 3.37	3.47 %	$ 908 M	Israel
Avid Bioservices CDMO	63.2 M	-	-	$ 789 M	USA
Biogen BIIB	146 M	$ 182.61	0.35 %	$ 26.6 B	USA
Cerevel Therapeutics Holdings CERE	162 M	-	-	$ 7.29 B	USA
ContraFect Corporation CFRX	521 K	-	-5.16 %	$ 5.39 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Beam Therapeutics BEAM	82.3 M	$ 27.45	-5.05 %	$ 2.26 B	USA
BioMarin Pharmaceutical BMRN	190 M	$ 53.01	-1.51 %	$ 10.1 B	USA
BioNTech SE BNTX	244 M	$ 96.12	0.13 %	$ 27.2 B	Germany
Clearside Biomedical CLSD	61.8 M	-	-	$ 25.3 M	USA
Celsion Corporation CLSN	11.5 M	-	-6.63 %	$ 13.9 M	USA
Clovis Oncology CLVS	116 M	-	-7.23 %	$ 13 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Checkmate Pharmaceuticals CMPI	21.6 M	-	-	$ 231 M	USA
Chimerix CMRX	88.6 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	34.4 M	-	-	$ 401 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	64.7 M	$ 9.44	-1.82 %	$ 611 M	USA